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CASE REPORT A 52-year-old lady presented
to A&E in November 2001 with a history of an
injury to the upper outer quadrant of the left
breastseveralweeks previously. Onexamination
she had a markedly abnormal left breast. A
fungating tumour occupied the upper outer
quadrant of the breast with the rest ofthe breast
swollen, oedematous and very firm. Ultrasound
scan showed no focal mass but the entire breast
was abnormal with areas of low density and
interstitial oedema. An Ultrasound guided fine
needle aspirate revealed malignant cells. The
main differential diagnosis lay between a poorly
differentiated carcinoma and a high grade
lymphoma therefore a core biopsy was obtained.
Thecorebiopsysuggestedasmallcellcarcinoma
arising primarily within the breast. A staging CT
scan of chest and bone scan revealed liver and
bony metastases and chemotherapy was
commenced.
Following chemotherapy the breast lesion was
clinically smaller and the breast softer, but the
lesion was ulcerated andcausing alotofdistress.
A repeat CT scan confirmed the breast mass had
reducedsignificantly from 10cmto5cmhowever
liver metastatic deposits had increased in size
from amaximum diameter of3cm to amaximum
of4.5cm. MRI scan of spine revealed extensive
bone metastases throughout cervical, dorsal,
lumbarspine and sacrum. Toimprove herquality
of life she elected to undergo a left mastectomy
and axillary node clearance. At operation the
tumour was very vascular and she required a
bloodtransfusion post-operatively. Pathology of
the tumourwas very unusual foraprimary breast
carcinoma and further immunohistochemical
stains revealed a Merkel cell carcinoma. This
lady's clinicalpattern ofa 1Ocmbreastlumpwith
a small skin lesion was extremely unusual.
During her post-operative period she developed
low back pain which appeared to settle with
analgesia and she was re-admitted soon after
discharge with lower limb paralysis. MRI scan
revealed an extra-spinal cord deposit. She had
radiotherapy andchemotherapy withnoreturnof
powerin her legs. She subsequently deteriorated
very rapidly and sadly passed away.
DISCUSSION
Merkelcellcarcinoma(MCC) is ararecutaneous
neoplasm first described by Toker in 1972 as
'trabecularcarcinoma'. Merkelcellsarebelieved
to be primary neuroendocrine cells found within
thebasallayerofthedermis. Ithasbeenshownto
be a highly aggressive and lethal tumour,
comparable with small-cell lung cancer and
melanoma in its behaviour with regards to
recurrence, metastatic spread, andmortality. Itis
adiseaseoftheelderly, withanaverageageatthe
time ofdiagnosis of69 years. It affectsprimarily
the sun exposed areas ofthe skin especially head
andneck.Littleisknownaboutspecificaetiologic
factors in the pathogenesis of MCC, however,
like melanoma, ultraviolet radiation appears to
be a significant factor with respect to both its
anatomic and geographical distribution.
Patients typically present with a reddish blue,
firm, non tender, nodular mass that has grown
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rapidly over a few weeks to months and which
may ulcerate. Due to its non-specific appearance
diagnosis is generally not made before biopsy
and is then based on immunohistochemical
stainingforcytokeratin20.Diagnosticevaluation
includes CT imaging, octreotide and PET scans.
Treatment is by wide surgical excision of the
primary tumour and chemotherapy, followed by
radiotherapyforpatients withadvancedlocaland
regionalspread. Typicalspreadistolymphnodes,
liver,lungandbones. MCChasalocalrecurrence
rate of 40-44% after primary treatment, a 55%
rateoflymphnodemetastases, anda34-49% rate
of distant metastases with the majority of
recurrences appearing within the first six to 12
months after initial diagnosis. Due to the rare
occurrence of MCC, no prospective clinical
studies assessing initial surgical therapy,
radiotherapy, or chemotherapy have been
performed.
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